# Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia

> **NCT04491682** · PHASE2,PHASE3 · COMPLETED · sponsor: **Fudan University** · enrollment: 36 (actual)

## Conditions studied

- Atypical Endometrial Hyperplasia

## Interventions

- **DRUG:** Megestrol Acetate
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT04491682
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2022-06-20
- **Final completion:** 2022-06-20
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04491682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04491682, "Megestrol Acetate Plus Rosuvastatin in Young Women With Atypical Endometrial Hyperplasia". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04491682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*